Rankings
▼
Calendar
XOMAP Q3 2017 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena
XOMAP
XOMA Corporation
$309M
Q3 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$36M
+5598.1% YoY
Gross Profit
$35M
97.2% margin
Operating Income
$29M
79.2% margin
Net Income
$26M
72.8% margin
EPS (Diluted)
$2.33
QoQ Revenue Growth
+232.3%
Cash Flow
Operating Cash Flow
$31M
Free Cash Flow
$31M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$50M
Total Liabilities
$46M
Stockholders' Equity
$4M
Cash & Equivalents
$48M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$36M
$635,000
+5598.1%
Gross Profit
$35M
-$8M
+537.6%
Operating Income
$29M
-$12M
+336.9%
Net Income
$26M
-$13M
+310.3%
← FY 2017
All Quarters
Q4 2017 →